+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Phase 2
Age: 18Years +
All Genders
ID06511050

Study of Lumbrokinase Treatment for Adults with Long Covid, Post-treatment Lyme Disease Syndrome, or Chronic Fatigue Syndrome

Led by Icahn School of Medicine at Mount Sinai · Updated on 2026-03-13

120

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of Lumbrokinase LK, a dietary supplement, in adults with Long Covid, Post-treatment Lyme Disease Syndrome PTLDS, and Myalgic EncephalomyelitisChronic Fatigue Syndrome MECFS. This pilot multi-arm clinical trial aims to investigate the feasibility of Lumbrokinase as an intervention across these three conditions, which share overlapping symptoms and impacts on health. The study is sponsored by the Icahn School of Medicine at Mount Sinai and includes adults aged 18 and older. Participants in this study will take Boluoke4 brand lumbrokinase capsules, each containing 300,000 functional units, twice daily for a total of 6 weeks. The trial includes three experimental groups, one for each condition Long Covid, Post-treatment Lyme Disease Syndrome, and MECFS. There is no randomization or placebo control, and all participants receive the same dose and schedule of Lumbrokinase. Throughout the 12-week study period, participants will be monitored and assessed with various tools to measure quality of life, physical function, cognitive ability, symptoms, and mental health. Assessments include the EuroQol Visual Analogue Scale, 10-Meter Walk Test, cognitive batteries, and symptom questionnaires like the Fatigue Severity Scale and anxiety and depression screens. Safety and adherence will be tracked, and data collected up to 12 weeks after starting the treatment.

CONDITIONS

Brief Title

Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Research Team

D

David Putrino, PhD, PT

M

Mackenzie Doerstling, MPH

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here